Market forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis

Department of Health and Human Services · CENTERS FOR DISEASE CONTROL AND PREVENTION · Combined Synopsis/Solicitation · 97469

posted 17 August 2026 · closed 2 September 2026 · NAICS 541715 · PSC AN11 · 3 postings

Summary

The CDC is seeking contractor support to conduct two comprehensive market forecast analyses for a human West Nile virus vaccine and an anti‑WNV monoclonal antibody intended for seasonal pre‑exposure prophylaxis. The effort will include epidemiologic analysis, health‑economic modeling, stakeholder engagement, commercial assessment, financial analysis, and preparation of peer‑reviewed publications. No further technical detail beyond the scope of market forecasting is provided.

View the official notice ↗

Want to know why the government is buying what they buy? Subscribe to the OODA Daily Pulse

The OODA Daily Pulse Report provides a detailed summary of the top technology, cybersecurity and global risks of the day. Our analysts curate stories, articles and insights from hundreds of vetted sources to inform your decisions and our research team provides long form context on topics destined to be of importance. Delivered free to your inbox five days a week at 10:00am.